Leishmania is not prone to develop resistance to tamoxifen

Tamoxifen, an antineoplastic agent, is active in vitro and in vivo against the parasitic protozoa Leishmania. As part of our efforts to unravel this drug's mechanisms of action against the parasite and understand how resistance could arise, we tried to select tamoxifen-resistant Leishmania amaz...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Adriano C., Trinconi, Cristiana T., Senra, Luisa, Yokoyama-Yasunaka, Jenicer K.U., Uliana, Silvia R.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486464/
https://www.ncbi.nlm.nih.gov/pubmed/26150922
http://dx.doi.org/10.1016/j.ijpddr.2015.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486464/
https://www.ncbi.nlm.nih.gov/pubmed/26150922
http://dx.doi.org/10.1016/j.ijpddr.2015.05.006

Ejemplares similares